Health
Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus – News-Medical.Net
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndr…
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells. This drug could potentially be used to prevent virus infection. The research is published on the bioRxiv* preprint server in September 2020.
To combat the spread of COVID-19, researche…
-
Noosa News20 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
General23 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News18 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General23 hours agoDisloyal far-left breakaways are coming for Labor